Rock Creek Group’s Boston Scientific BSX Stock Holding History

Rock Creek Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-195	Closed	-$10.3K	–	85
2023 Q3	$10.3K	Sell	195 -117	-38%	-$6.14K	﹤0.01%	169
2023 Q2	$16.9K	Buy	312 +41	+15%	+$2.14K	﹤0.01%	153
2023 Q1	$13.6K	Buy	271 +48	+22%	+$2.26K	﹤0.01%	168
2022 Q4	$10.3K	Hold	223	–	–	﹤0.01%	150
2022 Q3	$9K	Hold	223	–	–	﹤0.01%	159
2022 Q2	$8K	Hold	223	–	–	﹤0.01%	152
2022 Q1	$10K	Hold	223	–	–	﹤0.01%	161
2021 Q4	$9K	Buy	223 +55	+33%	+$2.31K	﹤0.01%	200
2021 Q3	$7K	Buy	168 +19	+13%	+$841	﹤0.01%	172
2021 Q2	$6K	Buy	+149	New	+$6.27K	﹤0.01%	178
2019 Q4	–	Sell	-26,698	Closed	-$1.09M	–	118
2019 Q3	$1.09M	Buy	26,698 +7,232	+37%	+$306K	0.52%	53
2019 Q2	$837K	Buy	+19,466	New	+$749K	0.38%	58
2019 Q1	–	Sell	-15,027	Closed	-$531K	–	86
2018 Q4	$531K	Buy	+15,027	New	+$545K	0.23%	69

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rock Creek Group's BSX Position: Q4 2023 in Review

Rock Creek Group sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 195 shares — an estimated $10.3K sold.

Rock Creek Group first reported a position in BSX in Q4 2018 and held it in 13 quarters. The position peaked at $1.09M in Q3 2019. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

Rock Creek Group reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
Rock Creek Group sold 195 Boston Scientific shares in Q4 2023, an estimated $10.3K.
Rock Creek Group first reported a position in Boston Scientific in Q4 2018 and held it in 13 quarters.
Rock Creek Group's Boston Scientific position peaked at $1.09M in Q3 2019.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.